7 results  1 of 1 

1 Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Jae Joon Han
Blood Res.2023;58(S1):S58-S65.   Published online 2023 April 7     DOI: http://dx.doi.org/10.5045/br.2023.2023035
      
2 A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
Blood Res.2021;56(4):229-242.   Published online 2021 December 31     DOI: http://dx.doi.org/10.5045/br.2021.2021117
      
3 Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review
Jae-Ki Choi, Sung-Yeon Cho, Su-Mi Choi, Gyo Hui Kim, Sung-Eun Lee, Seok Lee, Dong-Wook Kim, Dong-Gun Lee
Infect Chemother.2018;50(2):153-159.   Published online 2018 June 8     DOI: http://dx.doi.org/10.3947/ic.2018.50.2.153
      
4 Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
Ji Hyung Hong, Sung-Eun Lee, Soo Young Choi, Soo-Hyun Kim, Eun-Jung Jang, Ju-Hee Bang, Jin Eok Park, Hye-Rim Jeon, Yun Jeong Oh, Jeong-Eun Yi, Hae Ok Jung, Ho Joong Youn, Dong-Wook Kim
Cancer Res Treat.2015;47(4):937-942.   Published online 2014 November 17     DOI: http://dx.doi.org/10.4143/crt.2013.155
      
5 Development of Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia
Hawk Kim
Hanyang Med Rev.2012;32(2):103-111.   Published online 2012 May 25     DOI: http://dx.doi.org/10.7599/hmr.2012.32.2.103
      
6 Recent advances in the path toward the cure for chronic myeloid leukemia
Dong-Wook Kim
Korean J Hematol.2011;46(3):169-174.   Published online 2011 September 30     DOI: http://dx.doi.org/10.5045/kjh.2011.46.3.169
      
7 Coexisting with Clonal Evolution and BCR-ABL Mutant in CML Patients Treated with Second-generation Tyrosine Kinase Inhibitors Predict the Discrepancy of in vitro Drug Sensitivity
Jae-Sook Ahn, Yeo-Kyeoung Kim, Se Ryeon Lee, Li Yu, Deok-Hwan Yang, Sang-Hee Cho, Hyun Jeong Shim, Woo Kyun Bae, Je-Jung Lee, Ik-Joo Chung, Myung Gun Shin, Hyeoung-Joon Kim
Cancer Res Treat.2010;42(1):37-41.   Published online 2010 March 31     DOI: http://dx.doi.org/10.4143/crt.2010.42.1.37
      

 1 of 1